Gaydamak turns to tin

Russian-Israeli investor Arkadi Gaydamak agreed to buy a 45 percent stake in Willy Food Investments Ltd., an Israeli importer of canned pickles, fish and dried fruit, for $40.5 million.

By TAL BARAK
June 25, 2007 07:53
Arkadi Gaydamak 88 298

Arkadi Gaydamak 88 298. (photo credit: Ariel Jerozolimski)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Russian-Israeli investor Arkadi Gaydamak agreed to buy a 45 percent stake in Willy Food Investments Ltd., an Israeli importer of canned pickles, fish and dried fruit, for $40.5 million. Gaydamak will buy 3.9 million shares from shareholders Joseph and Zvi Williger, Yavne-based Willy Food Investments said in a statement to the Tel Aviv Stock Exchange on June 23. Gaydamak last week backtracked from buying control of Tiv Taam Holdings 1 Ltd., Israel's biggest non-kosher supermarket.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS